HAYLEY KAELIN: Open Payments
NPI 1891397626 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,407 in 137 payments from 22 companies in 2025. Trend: 2023 $1,934 · 2024 $2,164 · 2025 $2,407
Food & beverage: $2,296Education: $111
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 21 | $417 |
| ABBVIE INC. | 20 | $286 |
| Teva Pharmaceuticals USA, Inc. | 8 | $255 |
| Otsuka America Pharmaceutical, Inc. | 10 | $218 |
| Supernus Pharmaceuticals, Inc. | 17 | $175 |
| Lundbeck LLC | 16 | $172 |
| Corium, LLC | 9 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $140 |
| Janssen Pharmaceuticals, Inc | 4 | $101 |
| Neurocrine BioSciences, Inc. | 4 | $81 |
Products named: Auvelity, REXULTI, VRAYLAR, Qelbree, Azstarys, CAPLYTA, SPRAVATO, AUSTEDO XR.
Industry payments across IN — which companies pay providers there.
